TD has acquired Cowen Inc. Please bookmark TD Securities for further updates.

$119 Million

NanoString Technologies Inc

Follow-on Offering

Bookrunner, March 2019

NanoString Technologies Inc
NanoString Technologies provides life science tools for translational research and molecular diagnostic products. The company's lead product, the nCounter Analysis System, has been employed in life sciences research since it was first introduced in 2008 and has been cited in more than 2,300 peer-reviewed publications. The nCounter Analysis System offers a cost effective way to easily profile the expression of hundreds of genes, proteins, miRNAs, or copy number variations, simultaneously with high sensitivity and precision. The process allows for the facilitation of a wide variety of basic research and translational medicine applications, including biomarker discovery and validation. The nCounter platform provides for multiplex analysis of up to 800 RNA, DNA, or protein targets